These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 9200008

  • 21. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.
    Shan PF, Wu XP, Zhang H, Luo XH, Cao XZ, Xie H, Liu SP, Pi YZ, Fang TY, Liu H, Chen ZH, Zhong N, Liao EY.
    Clin Chim Acta; 2006 Apr; 366(1-2):233-8. PubMed ID: 16330011
    [Abstract] [Full Text] [Related]

  • 22. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 23. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
    Guo LJ, Luo XH, Wu XP, Xie H, Zhou HD, Zhang H, Cao XZ, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):734-7. PubMed ID: 15949377
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P, Delmas PD.
    J Musculoskelet Neuronal Interact; 2004 Mar 22; 4(1):50-63. PubMed ID: 15615078
    [Abstract] [Full Text] [Related]

  • 31. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP, Liao EY, Wu XP, Cao XZ, Shan PF, Su X.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):371-5. PubMed ID: 16677543
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS, Maimani AA, Bahksh TA, Rouzi AA, Qari MH, Raddadi RM.
    Bone; 2010 Oct 14; 47(4):804-14. PubMed ID: 20659600
    [Abstract] [Full Text] [Related]

  • 34. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures.
    Bauer DC, Sklarin PM, Stone KL, Black DM, Nevitt MC, Ensrud KE, Arnaud CD, Genant HK, Garnero P, Delmas PD, Lawaetz H, Cummings SR.
    J Bone Miner Res; 1999 Aug 14; 14(8):1404-10. PubMed ID: 10457273
    [Abstract] [Full Text] [Related]

  • 35. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD.
    J Clin Endocrinol Metab; 1994 Dec 14; 79(6):1693-700. PubMed ID: 7989477
    [Abstract] [Full Text] [Related]

  • 36. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
    Jiang LS, Zhang ZM, Jiang SD, Chen WH, Dai LY.
    J Bone Miner Res; 2008 Apr 14; 23(4):475-83. PubMed ID: 18052758
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Changes in bone mass and bone turnover following ankle fracture.
    Ingle BM, Hay SM, Bottjer HM, Eastell R.
    Osteoporos Int; 1999 Apr 14; 10(5):408-15. PubMed ID: 10591839
    [Abstract] [Full Text] [Related]

  • 39. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC.
    Osteoporos Int; 2000 Apr 14; 11(4):295-303. PubMed ID: 10928218
    [Abstract] [Full Text] [Related]

  • 40. Dose-response relationships between energy availability and bone turnover in young exercising women.
    Ihle R, Loucks AB.
    J Bone Miner Res; 2004 Aug 14; 19(8):1231-40. PubMed ID: 15231009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.